These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7168571)

  • 1. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.
    Aman MG; Singh NN
    Appl Res Ment Retard; 1982; 3(4):345-58. PubMed ID: 7168571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.
    Aman MG
    J Autism Dev Disord; 1982 Dec; 12(4):385-98. PubMed ID: 6131061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients--a pilot study.
    Aman MG; White AJ; Field C
    J Ment Defic Res; 1984 Dec; 28 ( Pt 4)():253-60. PubMed ID: 6396416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance.
    Aman MG; Marks RE; Turbott SH; Wilsher CP; Merry SN
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):816-24. PubMed ID: 1938800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment.
    Aman MG; Singh NN
    J Ment Defic Res; 1985 Jun; 29 ( Pt 2)():187-95. PubMed ID: 2863380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.
    Aman MG; White AJ
    J Autism Dev Disord; 1988 Sep; 18(3):355-66. PubMed ID: 3170454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons.
    Millichamp CJ; Singh NN
    Res Dev Disabil; 1987; 8(2):213-27. PubMed ID: 2890189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.
    Aman MG; Kern RA; McGhee DE; Arnold LE
    J Autism Dev Disord; 1993 Sep; 23(3):491-506. PubMed ID: 8226583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.
    Aman MG; Buican B; Arnold LE
    J Child Adolesc Psychopharmacol; 2003; 13(1):29-40. PubMed ID: 12804124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
    Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients.
    Reid AH; Naylor GJ; Kay DS
    Psychol Med; 1981 Feb; 11(1):109-13. PubMed ID: 7208734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study of imipramine in profoundly retarded residents.
    Aman MG; White AJ; Vaithianathan C; Teehan CJ
    J Autism Dev Disord; 1986 Sep; 16(3):263-73. PubMed ID: 3549681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.